How to Get Wegovy Online Legally: Step-by-Step Guide (2026)

To get Wegovy online legally, you complete a consultation with a licensed clinician (in person or via telehealth), and if they decide it's clinically appropriate, they write a prescription that a licensed pharmacy fills. That's it. There is no legitimate shortcut around the prescription. The decision points along the way are: (1) do you meet the clinical criteria a clinician will assess, (2) do you want genuine brand Wegovy or are you considering compounded semaglutide, and (3) which provider or pharmacy you use to route it all.

Everything below is the long version of that sentence.

Wegovy is Novo Nordisk's brand name for semaglutide, a once-weekly injectable in the GLP-1 receptor agonist class. It is FDA-approved and prescription-only. Per its FDA label, it is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with obesity or overweight with at least one weight-related condition, and for certain adolescents aged 12 and older who meet BMI criteria. (Novo Nordisk also markets semaglutide as Ozempic for type 2 diabetes and Rybelsus as an oral tablet — different products, different approved uses.)

Here is the distinction that trips people up: "compounded semaglutide" is not the same as Wegovy. Compounded medications are mixed by compounding pharmacies and are not FDA-approved — the FDA does not review them for safety, effectiveness, or quality the way it does brand drugs. The FDA has warned about compounded semaglutide, including dosing errors and products using different salt forms of the drug. Compounded versions are legal to dispense only under specific conditions and a valid prescription. None of that makes them inherently usable or unusable for you — that's a clinician's call — but you should always know which one you're being offered.

You don't self-diagnose eligibility, and a website quiz doesn't decide it — a licensed clinician does. But it helps to know roughly what they're assessing, drawn from the FDA-approved label and standard practice:

• Adults: a BMI of 30 or higher (obesity), or a BMI of 27 or higher (overweight) with at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol.
• Adolescents (12+): specific BMI criteria for their age and sex, per the label.
• Plus a review of your medical history, current medications, and contraindications. Per the label, Wegovy carries a boxed warning regarding thyroid C-cell tumors observed in rodent studies, and it should not be used by people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.

This is a factual sketch of label criteria, not a promise that you qualify or a prediction of any result. Bring questions; a good clinician will welcome them.

Two broad legal paths exist online. Both require a consultation and a prescription.

Manufacturer-direct. Novo Nordisk operates NovoCare Pharmacy and direct-to-patient programs that can deliver genuine, FDA-approved brand Wegovy to eligible patients, including cash-pay self-pay pricing for those without coverage. Because it comes straight from the maker, you know exactly what you're getting. (Eli Lilly runs a comparable model, LillyDirect, but note Lilly's GLP-1s are Zepbound and Mounjaro — tirzepatide — not Wegovy.)

Telehealth providers. A large field of telehealth companies handles the online visit and, if a clinician prescribes, routes the script to a pharmacy. Some offer brand Wegovy; many lead with compounded semaglutide at a lower bundled price. Reputable, frequently-discussed options in this space include Ro, Hims & Hers, Found, Mochi Health, Calibrate, Noom Med, LifeMD, PlushCare, WeightWatchers Clinic, and Form Health, among others. The single most important question to ask any of them, in writing: am I getting brand-name FDA-approved Wegovy, or compounded semaglutide? The answer changes the price, the regulatory status, and your expectations.

A legitimate telehealth visit involves a real licensed clinician — a physician, nurse practitioner, or physician assistant — reviewing your case. Expect to provide an accurate medical history, current medications and allergies, height and weight, and sometimes recent labs or a blood-pressure reading. Many providers use an asynchronous questionnaire followed by clinician review; some include a live video visit. Either way, a human licensed in your state should be making the prescribing decision.

Be honest. Omitting a medication or condition to clear a quiz isn't a hack — it removes the safety check the consultation exists to provide. If a service approves you in seconds with no apparent clinician review and no questions about your history, treat that as a warning sign, not a feature.

If the clinician prescribes, the prescription goes to a pharmacy — the manufacturer's pharmacy, a partner pharmacy, or (for compounded products) a licensed compounding pharmacy. Brand Wegovy is dispensed in prefilled, single-dose pen injectors at escalating doses; the label describes a gradual dose-escalation schedule to help manage side effects. Most online routes ship to your door with cold-chain handling where required, plus instructions and dose-titration guidance.

What to confirm before you pay: the exact product and formulation, the dose schedule, what's included in the price (visit fees, medication, supplies, follow-ups), the refill and cancellation policy, and how clinician follow-up works if you have side effects or questions. Reputable providers make all of this easy to find.

The legal path always runs through a consultation and a licensed pharmacy. Walk away from any site that shows these signs:

• "No prescription needed" / "no consultation required." Prescription-only means prescription-only. This is the brightest red flag there is.
• Selling "research chemicals," "not for human use," or peptide vials by the milligram. Grey-market and research-chemical semaglutide is not a medicine you take — avoid entirely.
• Prices that are too good to be true, especially with no clarity on whether it's brand or compounded.
• No licensed pharmacy named, no clinician identified, no U.S. address, or pressure to pay by wire/crypto.
• Claims of guaranteed results or disease cures. No legitimate provider promises outcomes.
• Vague answers when you ask, directly, "Is this FDA-approved brand Wegovy or compounded semaglutide?"

When in doubt, the FDA's BeSafeRx resources and your state board of pharmacy can help you check whether an online pharmacy is legitimate.

Verifiable: Wegovy is FDA-approved brand-name semaglutide from Novo Nordisk; its label sets out the BMI-based indications, the boxed warning, and the dose-escalation approach summarized above. NovoCare Pharmacy is Novo Nordisk's own direct-dispensing channel, and LillyDirect is Eli Lilly's manufacturer-direct telehealth model (for Lilly's GLP-1s, not Wegovy). Compounded semaglutide is, by definition, not FDA-approved.

Not verifiable in a static article: exact current prices, real-time stock, which specific telehealth providers are offering brand Wegovy versus compounded semaglutide this week, and your personal eligibility. Manufacturer programs, pricing, and supply have changed repeatedly. We do not test medications, and we don't accept payment for placement. Verify every price and formulation at the source, and let a licensed clinician — not a website — decide what's appropriate for you.

This article is for adults 18 and older and is educational, not medical advice. It does not diagnose, treat, cure, or prevent any condition, and nothing here is a promise of any result. A prescription for Wegovy or any GLP-1 requires a consultation with a licensed clinician who determines whether it's appropriate for you. Compounded semaglutide is not FDA-approved. Prices are provider-attributed, change frequently, and should be verified at the source. GLP-1 Samples links to independent, licensed telehealth providers and pharmacies; it does not sell, ship, prescribe, or compound medication, and placement is never for sale.